VAC14

Protein VAC14 homolog · Q08AM6 · VAC14 on Sugi Atlas →

0 patent compounds predicted against VAC14, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to VAC14 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Long-term Immunogenicity After Receipt of JE Vaccine and Antibody Response and Safety to a Booster Dose PHASE4COMPLETED
Novel Peptide Vaccination for Patients With Advanced Prostate Cancer PHASE1/PHASE2UNKNOWN
Melpida: Recombinant Adeno-associated Virus (serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt) PHASE1/PHASE2RECRUITING
Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer PHASE1/PHASE2COMPLETED
Phase I Safety and Immunogenicity Preventative Vaccine Trial Based on Recombinant Tat Protein PHASE1COMPLETED
Nilotinib in Huntington's Disease PHASE1UNKNOWN
The Effects of GLA on Human Volunteers PHASE1COMPLETED
Safety Study of Cancer Specific Epitope Peptides Cocktail for Cervical, GI, and Lung Tumors PHASE1COMPLETED
The Treatment of Advanced Lung Cancer With Dribbles Antigen by Targeting Activation of Tcells PHASE1UNKNOWN
Clinical and Genetic Studies of VACTERL Association nanCOMPLETED
Genetic Analysis of Immune Disorders nanRECRUITING
Identification of an Asthma Susceptibility Gene on 3P nanCOMPLETED
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis nanUNKNOWN
Genetic Overlap Between Anomalies and Cancer in Kids in the Children's Oncology Group: The COG GOBACK Study nanACTIVE_NOT_RECRUITING
New Strategies of Genetic Study of Patients With Oculocutaneous Albinism nanCOMPLETED
Study of the Pathophysiological Mechanisms Involved in Bleeding Events nanCOMPLETED
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA nanRECRUITING
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Study of the Genetic and Epigenetic Causes of Recurrent Hydatidiform Moles nanACTIVE_NOT_RECRUITING
Developing Newborn Screening for Infants With Primary Immunodeficiency nanCOMPLETED
Genetic Characterization of Parkinson's Disease nanCOMPLETED
Genome Medical Sequencing for Gene Discovery nanRECRUITING
Genetic Variants in Nicotinamide Adenine Dinucleotide (NAD) Synthesis Pathway nanCOMPLETED
Lipa Gene Mutation in PED-LIPIGEN (Pediatric FH Subjects) nanUNKNOWN
Immune Response to Varicella-Zoster Vaccination and Infection nanCOMPLETED
New Genes Involved in Molecular Etiology of Rett Syndrome Through DNA Microarray Comparative Genomic Hybridization nanCOMPLETED
Exome Analysis in Hearing Impaired Patients nanUNKNOWN
Study of Chediak-Higashi Syndrome nanRECRUITING
Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors nanRECRUITING
Delineating the Molecular Spectrum and the Clinical, Imaging and Neuronal Phenotype of Chopra-Amiel-Gordon Syndrome nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a VAC14 binder may also engage these)

ProteinNameSimilarity
A2VE70 1.000 A2VE70 →
Q80W92 1.000 Q80W92 →
Q66L58 1.000 Q66L58 →
Q80WQ2 1.000 Q80WQ2 →
Q68F38 1.000 Q68F38 →
Q5ZIW5 0.999 Q5ZIW5 →
Q9ZU97 0.995 Q9ZU97 →
Q8RW96 0.994 Q8RW96 →
A4FV68 0.993 A4FV68 →
Q6PD03 0.992 Q6PD03 →
Q6I621 0.992 Q6I621 →
PPP2R5A Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform 0.992 landscape →
Q80W83 0.992 Q80W83 →
Q9ZQY6 0.991 Q9ZQY6 →
O04376 0.991 O04376 →
Q9SV41 0.991 Q9SV41 →
Q28651 0.991 Q28651 →
Q6PD28 0.990 Q6PD28 →
Q9LU89 0.990 Q9LU89 →
Q8IV36 0.990 Q8IV36 →
Q16537 0.990 Q16537 →
Q9ESE1 0.989 Q9ESE1 →
Q0V9L1 0.989 Q0V9L1 →
O94915 0.989 O94915 →
B2RXC1 0.989 B2RXC1 →
O35638 0.989 O35638 →
Q9D3E6 0.989 Q9D3E6 →
Q9DGN0 0.989 Q9DGN0 →
Q7Z392 0.989 Q7Z392 →
Q93YV6 0.988 Q93YV6 →